Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Not yet recruitingOBSERVATIONAL

Enrollment

280

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions

Quality of Life

Interventions

DRUG

Cabotegravir, Rilpivirine Drug Combination

Treatment switch to CAB+RPV LA

All Listed Sponsors

collaborator

Hopital Foch

OTHER

lead

University Paris 7 - Denis Diderot

OTHER

NCT06403865 - Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine | Biotech Hunter | Biotech Hunter